Trialect

+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Not Verified

Expired

Academy of Kidney Cancer Investigators – Early-Career Scholar Award

Department of Defense(DOD)

Program Description

Applications to the Fiscal Year 2022 (FY22) Kidney Cancer Research Program (KCRP) are being solicited by the U.S. Army Medical Research Acquisition Activity (USAMRAA) using delegated authority provided by United States Code, Title 10, Section 4001 (10 USC 4001). The execution management agent for this program announcement is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Development Command (USAMRDC). The KCRP was initiated in 2017 to provide support for research of exceptional scientific merit in the area of kidney cancer. Appropriations for the KCRP from FY17 through FY21 totaled $135 million (M). The FY22 appropriation is $50M.

The proposed research must be relevant to active-duty Service Members, Veterans, military beneficiaries, and/or the American public.

Specialties

Cancer

Nephrology

Oncology

Eligibility Requirements

Eligible Applicants

Organization: All organizations, including foreign organizations, foreign public entities, and international organizations, are eligible to apply.

Government Agencies Within the United States: Local, state, and federal government agencies are eligible to the extent that applications do not overlap with their fully funded internal programs. Such agencies are required to explain how their applications do not overlap with their internal programs.

As applications for this program announcement may be submitted by extramural and intramural organizations, these terms are defined below.

Extramural Organization: An eligible non-DOD organization. Examples of extramural organizations include academic institutions, biotechnology companies, foundations, federal government organizations other than the DOD, and research institutes.

Intramural DOD Organization: A DOD laboratory, DOD military treatment facility, and/or DOD activity embedded within a civilian medical center. Intramural Submission: An application submitted by a DOD organization for an intramural investigator working within a DOD laboratory or military treatment facility or in a DOD activity embedded within a civilian medical center.

The USAMRAA makes awards to eligible organizations, not to individuals.

Principal Investigator

Each Scholar may be named on only one KCRP AKCIECSA application as a PI.

Early-Career Scholar
Must be less than 4 years from their last postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent as of the full application submission deadline.
A Statement of Eligibility is required with the submission of the full application.
Individuals in a postdoctoral research position (Ph.D.), clinical fellowship (M.D.), or equivalent, at the time of the full application submission deadline, are not eligible.
May be a research- or physician-scientist.
Must commit no less than 25% effort to this award for the first 2 years.
Designated Mentor
Must be an independent, established kidney cancer investigator with a record of kidney cancer publications in peer-reviewed journals.
May be at the same institution as the ECS.
If not at the same institution, another mentor (“Other Mentor,” see below) at the ECS’s institution must also be included in the application submission.
Must demonstrate a commitment (at least 5% effort for mentoring and participating in Academy activities, e.g., offsite meetings and webinars) to develop and sustain the ECS’s independent career in kidney cancer research.
Mentoring responsibilities include mentoring the ECS (i.e., the PI of this award) and an additional ECS within the Academy.
An AKCI Designated Mentor may serve as a Designated Mentor to only one AKCI-ECS.
The Dean of the Academy may not be listed as a Designated Mentor.
Off-site Academy activities include annual in-person workshops and monthly web-based meetings.
Other Mentor (if applicable)
Must be at the same institution as the ECS.
Must be an independent researcher, with relevant expertise but not necessarily in kidney cancer.
Must show cancer research funding (past and present).

An eligible PI, regardless of ethnicity, nationality, or citizenship status, must be employed by, or affiliated with, an eligible organization.

The CDMRP strongly encourages all PIs to participate in a digital identifier initiative through Open Researcher and Contributor ID, Inc. (ORCID). Registration for a unique ORCID identifier can be done online at https://orcid.org/.

Cost Sharing

Cost sharing/matching is not an eligibility requirement.

Other

Organizations must be able to access .gov and .mil websites in order to fulfill the financial and technical deliverable requirements of the award and submit invoices for payment.

Eligible Countries:

Sponsor Details

Sponsor Institute/Organizations: Department of Defense(DOD)

Sponsor Type:

Address: 1400 Defense Pentagon; Washington, DC 20301-1400;United States

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity